Parenteral Drug Association
Connecting People, Science and Regulation ®
by: PDA, Inc.
by: Douglas Campbell
by: Qifeng Zhang, PhD, Lonza
PDA, Inc.
Tamer Helmy, PhD, Molecular Templates Inc.
Mary Oates, Emergent BioSolutions
G (Som) Somasundaram and Priyabrata Pattnaik, PhD, Merck Life Science
Bettine Boltres, West Pharmaceutical Services Deutschland GmbH & Co KG and Lee Leichter, P/L Biomedical
PDA Southern California Chapter
Bob Myers, PDA
Stephan Krause, Adele Chambers, Ryan Courtney, Darrin Cowley, and Anthony Mire-Sluis, AstraZeneca
Richard Johnson, PDA
Ray Roggero, Medvacon Life Sciences
Marilyn Foster, PDA, Inc.
Bettine Boltres, West Pharmaceutical Services Deutschland GmbH & Co KG
Richard M. Johnson, President, PDA Foundation
Marilyn L. Foster, PDA
Klaus Wuchner, Janssen, et al.
PDA Letter
Task Force Co-Chairs Eva M. Urban, CSL Behring, and Tiffany Baker, ValSource, LLC
Brett Hoffmeister, Associates of Cape Cod, Inc., Allen Burgenson, Lonza, and John Dubczak, Charles River Laboratories
Richard Chai, STERIS Corporation, Priyabrata Pattnaik, Merck Pte. Ltd., and Bruce Loxley, GSK
John Ayres, MD, Pharma Safety Solutions, LLC and Rob Miller, MS, Pfizer Inc.
M. Amin Khan and Cristiana Campa, GSK
Tony Cundell, PhD, Microbiological Consulting, LLC and PDA COVID-19 Pandemic Task Force
John Shabushnig, PhD, Insight Pharma Consulting, LLC
Claire Briglia, Vedere Solutions
Justin Ratzan-Wank, Master of Business and Science Candidate, Keck Graduate Institute
Tia Bush, Amgen, Inc.
Martin Van Trieste, President & CEO, Civica Rx
Jason Kerr, Redica Systems
PDA Europe
Jette Christensen (Novo Nordisk), Chair PDA Board of Directors
Ziva Abraham, Microlite, Inc.
Michael De Felippis, Eli Lilly and Cristiana Campa, GSK Vaccines
Walter Morris, PDA
Marilyn Foster, PDA
Hal Baseman, ValSource, Gabriele Gori, GSK Vaccines, and Jahanvi Miller, PDA
Ali Ardakani, Novateur Ventures and Fenton Fong, xCellarate Technology
Tony Manzano, Aizon; Andrej Ondrack, Aizon; Kir Henrici, The Henrici Group
Ajay Babu Pazhayattil, Industrial Pharmacist
Subrata Chakraborty, GxPFONT Consulting Group
Fran DeGrazio and Diane Paskiet, West Pharmaceuticals Services, Inc.
Christine Roberts, PDA
Anna Gilbert, BDO; Robert Greathead, Catalent Pharma Solutions; Michelle Bernards, Manager, Catalent Pharma Solutions
Glenn Wright, PDA
West Coast Chapter
Robert Schaut, Kelly Murphy (formerly), Daniel Kramer, Christy Chapman, and Carol Rea Flynn, Corning Inc.
Michael J. Miller, PhD
Hal Baseman, Valsource, Inc and Annex 1 Response Team Co-Chair
PDA
Michael Blackton, Adaptimmune, LLC, and Stephan Krause, PhD, AstraZeneca Diagnostics; ATMP Advisory Board Co-Chairs
Kevin T. Moore, PhD, U. S. Pharmacopeia, and J. Mark Wiggins, Global Pharmacopoeia Solutions LLC
Brianna Kempker, Steris Corporation
Brian J. Hawkins, Raluca Marcu, Pluristyx, Inc.
Walt Morris, PDA
Matthew Paquette, Charles River
Kir Henrici, The Henrici Group, and Monica Cahilly, Green Mountain Quality Assurance, LLC
Rebecca Stauffer, PDA
Christy Wong, PDA Southern California Student Chapter President and Student, Keck Graduate Institute
Bernhard Hinsch, Hinsch Consulting
Angela Molaschi, Chapter President
Oliver Stauffer, PTI
Kevin Williams, bioMerieux
Gabriele Peron, Stevanato Group
Els Poff, Merck, and Technical Report Team Leader
Anil Sawant, PhD, Merck
William Peterson, Merck & Co.
Marten Ritz and Thomas Friedli, University of St. Gallen, Switzerland
Vladislav Shestakov, Russian State Institute of Drugs and Good Practices, and Elizabeth Meyers, Amgen